|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.16 HKD | -1.51% |
|
-2.98% | -2.55% |
| 05-14 | Hansoh Pharma Gets China Nod for Trial of Tumor Drug | MT |
| 05-13 | Hansoh pharmaceutical says HS-10541 tablets obtain clinical trial approval from China's NMPA | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 27.22B | |||||
| 896B | |||||
| 546B | |||||
| 372B | |||||
| 328B | |||||
| 283B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition